TXG 10x Genomics, Inc.

NASDAQ
$58.06

10x Genomics, Inc. (TXG) is confirmed to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.16 per share.

10x Genomics Beat Expectations, Raises Guidance
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Nov 5
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($0.16)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $71.81

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About 10x Genomics, Inc.

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.